Business
Starpharma pauses UK sales of COVID spray after regulator’s queries – Sydney Morning Herald
The Melbourne biotech has paused sales of its coronavirus fighting product after the UK medicines watchdog wrote to its distributor…
Australian biotech firm Starpharma has paused the sales of its coronavirus-fighting nasal spray in the United Kingdom after the British medicines regulator questioned promotional claims made about the product.
The ASX-listed firm applied the same active…
Continue Reading
-
Noosa News23 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General24 hours agoLabor to squeeze public service, sparking warnings of job losses
-
Noosa News24 hours agoQLS submits key budget requests – Proctor